Nanjing, China - From November 30 to December 3, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") attended the 10th Left Main & Coronary Bifurcation Summit ("CBS 2017") held in Nanjing of Jiangsu Province, and had in-depth communication with several overseas experts. The CBS 2017 was themed on "applying big data with well-designed RCT to obtain more clinical evidence for patients," "to incorporate new interventional technologies and procedures into the care of patients with complex bifurcation disease," "to integrate advances in hemodynamic evaluation and mechanisms into the treatment of patients with coronary bifurcations," and "to analyze and compare treatment options for patients with bifurcation lesions." The summit aims to build an academic exchange platform for Interventional cardiologist regarding the interventional treatment of coronary bifurcation lesions, through reports of the latest clinical trials, case analysis and discussions, as well as operation demonstrations and rebroadcasting.
During the conference, Dr. Ricardo Alves Da Costa from Brazil, Dr. Alfredo E. Rodriguez from Argentina, and Dr. Pierfrancesco Agostoni and Dr. Koen Teeuwen from the Netherlands were invited to complete three cases using Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®") in Nanjing First Hospital. Specifically, Dr. Alfredo E. Rodriguez performed a case in which Firehawk® was used to treat left anterior descending stenosis lesion, and Dr. Pierfrancesco Agoston and Dr. Koen Teeuwen implanted four Firehawk® stents in a complex CTO case. The two cases achieved good postoperative outcome and the physicians spoke highly of the excellent crossability, pushability of Firehawk®.
Taking the opportunity of this summit, Dr. Ricardo Alves Da Costa, Dr. Pierfrancesco Agostoni, and Dr. Koen Teeuwen were invited to visit MicroPort® and MicroPort® Self-Experience Center. They said they were impressed by the incredible innovation ability and diversified business of MicroPort®.
This summit further strengthened and promoted the academic exchange and cooperation between China and other countries, and at the same time, it enabled domestic and international experts of interventional therapy to get a deeper understanding in MicroPort® and its products. In the future, MicroPort® will continue to provide academic exchange platforms for Interventional cardiologists by attending more significant and influential academic events such as the CBS.